BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 10334625)

  • 1. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computerized connectivity approach for analyzing the structural basis of mutagenicity in Salmonella and its relationship with rodent carcinogenicity.
    Perrotta A; Malacarne D; Taningher M; Pesenti R; Paolucci M; Parodi S
    Environ Mol Mutagen; 1996; 28(1):31-50. PubMed ID: 8698045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A computer system of automated evaluation of structure-activity relationship of chemical mutagens].
    Fu ZD; Gu LJ; Chen WR
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Jan; 27(1):16-8. PubMed ID: 8325171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.
    Mayer J; Cheeseman MA; Twaroski ML
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):50-8. PubMed ID: 18023949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative predictivity of the transformation in vitro assay compared with the Ames test.
    Parodi S; Taningher M; Russo P; Pala M; Vecchio D; Fassina G; Santi L
    J Toxicol Environ Health; 1983; 12(4-6):483-510. PubMed ID: 6668607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of rodent carcinogens by an expert system.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Feb; 228(2):105-24. PubMed ID: 2300064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of structural concepts to evaluate the potential carcinogenicity of natural products.
    Rosenkranz HS; Liu M; Cunningham A; Klopman G
    SAR QSAR Environ Res; 1996; 5(2):79-98. PubMed ID: 8751816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity and mechanistic relationships: the effect of chemical overlap on structural overlap in data bases of varying size and composition.
    Liu M; Sussman N; Klopman G; Rosenkranz HS
    Mutat Res; 1996 Nov; 372(1):79-85. PubMed ID: 9003534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.